X
Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.
This is an entirely free service. No payments are to be made.Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.
This is an entirely free service. No payments are to be made.
| Login Failure | ||||||||
|
||||||||
| Sign Up | Forgot Password? | ||||||||
ChangeGSK Consumer dominates the Rs 26 bn Indian malted beverage market with a significant 70% share (in volume terms). Its white beverage brand 'Horlicks' pioneered the broadening of the malted beverage market in India. Horlicks alone, as a white beverage... More
Tiger Brands is South Africa’s largest food company. The company manufactures, processes and distributes food products which include milling and baking, confectioneries, general foods as well as edible oils and its derivatives. Tiger Brands wide rang... More
 GSK CONSUMER  TIGER BRANDS |
| EQUITY SHARE DATA | |||||
|---|---|---|---|---|---|
| GSK CONSUMER Mar-16 |
TIGER BRANDS Sep-13 |
GSK CONSUMER/ TIGER BRANDS |
5-Yr Chart Click to enlarge
|
||
| High | Rs | 6,771 | 146,056 | - | |
| Low | Rs | 5,448 | 116,412 | - | |
| Sales per share (Unadj.) | Rs | 1,024.4 | 614.7 | - | |
| Earnings per share (Unadj.) | Rs | 163.3 | 58.5 | - | |
| Cash flow per share (Unadj.) | Rs | 177.0 | 74.1 | - | |
| Dividends per share (Unadj.) | Rs | 70.00 | 3,771.40 | - | |
| Dividend yield (eoy) | % | 1.1 | 2.9 | 39.9% | |
| Book value per share (Unadj.) | Rs | 581.5 | 293.1 | - | |
| Shares outstanding (eoy) | m | 42.06 | 191.55 | - | |
| Bonus/Rights/Conversions | - | - | - | ||
| Price / Sales ratio | x | 6.0 | 213.5 | 2.8% | |
| Avg P/E ratio | x | 37.4 | 2,244.6 | 1.7% | |
| P/CF ratio (eoy) | x | 34.5 | 1,770.7 | 1.9% | |
| Price / Book Value ratio | x | 10.5 | 447.7 | 2.3% | |
| Dividend payout | % | 42.9 | 6,450.6 | 0.7% | |
| Avg Mkt Cap | Rs m | 256,959 | 25,137,838 | 1.0% | |
| No. of employees | `000 | 3.7 | 16.8 | 22.3% | |
| Total wages/salary | Rs m | 5,094 | 10,904 | 46.7% | |
| Avg. sales/employee | Rs Th | 11,548.5 | 7,028.3 | 164.3% | |
| Avg. wages/employee | Rs Th | 1,365.3 | 650.9 | 209.7% | |
| Avg. net profit/employee | Rs Th | 1,841.1 | 668.5 | 275.4% | |
| INCOME DATA | |||||
|---|---|---|---|---|---|
| Net Sales | Rs m | 43,087 | 117,737 | 36.6% | |
| Other income | Rs m | 2,788 | 164 | 1,700.4% | |
| Total revenues | Rs m | 45,875 | 117,901 | 38.9% | |
| Gross profit | Rs m | 8,349 | 19,061 | 43.8% | |
| Depreciation | Rs m | 574 | 2,998 | 19.2% | |
| Interest | Rs m | 8 | 1,740 | 0.5% | |
| Profit before tax | Rs m | 10,554 | 14,488 | 72.8% | |
| Minority Interest | Rs m | 0 | 94 | 0.0% | |
| Prior Period Items | Rs m | 0 | 0 | - | |
| Extraordinary Inc (Exp) | Rs m | 0 | 253 | 0.0% | |
| Tax | Rs m | 3,685 | 3,636 | 101.3% | |
| Profit after tax | Rs m | 6,869 | 11,199 | 61.3% | |
| Gross profit margin | % | 19.4 | 16.2 | 119.7% | |
| Effective tax rate | % | 34.9 | 25.1 | 139.1% | |
| Net profit margin | % | 15.9 | 9.5 | 167.6% | |
| BALANCE SHEET DATA | |||||
|---|---|---|---|---|---|
| Current assets | Rs m | 37,560 | 41,263 | 91.0% | |
| Current liabilities | Rs m | 18,153 | 36,319 | 50.0% | |
| Net working cap to sales | % | 45.0 | 4.2 | 1,072.6% | |
| Current ratio | x | 2.1 | 1.1 | 182.1% | |
| Inventory Days | Days | 39 | 63 | 62.2% | |
| Debtors Days | Days | 30 | 56 | 53.1% | |
| Net fixed assets | Rs m | 5,374 | 23,976 | 22.4% | |
| Share capital | Rs m | 421 | 83 | 507.7% | |
| Net worth | Rs m | 24,456 | 56,149 | 43.6% | |
| Long term debt | Rs m | 0 | 6,335 | 0.0% | |
| Total assets | Rs m | 44,988 | 109,354 | 41.1% | |
| Interest coverage | x | 1,336.9 | 9.3 | 14,332.2% | |
| Debt to equity ratio | x | 0 | 0.1 | 0.0% | |
| Sales to assets ratio | x | 1.0 | 1.1 | 89.0% | |
| Return on assets | % | 15.3 | 11.8 | 129.2% | |
| Return on equity | % | 28.1 | 19.9 | 140.8% | |
| Return on capital | % | 43.2 | 26.5 | 162.8% | |
| CASH FLOW | |||||
|---|---|---|---|---|---|
| From Operations | Rs m | 5,724 | 6,336 | 90.3% | |
| From Investments | Rs m | -1,569 | -14,309 | 11.0% | |
| From Financial Activity | Rs m | -2,792 | 1,855 | -150.5% | |
| Net Cashflow | Rs m | 1,363 | -6,118 | -22.3% | |
Compare GSK CONSUMER With: COCA COLA (US) NESTLE (Switz.) AVI LTD. (S. Africa)
Compare GSK CONSUMER With: RAJ OIL MILLS KWALITY DAIRY AGRO TECH FOODS NESTLE SANWARIA AGRO OILS
|
| |
Indian share markets finished some selling pressure in the final hour of trade to finish flat amid weak European markets.
While GSK consumer reported muted revenue growth, volumes are seen to be recovering.
GSK Consumer Healthcare declared results for the quarter ended September 2016. The revenues dropped by 1.3% during the quarter as compared to a year ago; while the profits declined by 16.6% YoY during the quarter.
GSK Consumer Healthcare has announced the first quarter results of the financial year 2016-2017 (1QFY17). The company's sales declined by 1.4% YoY while net profit rose by 2.9% YoY during the quarter.
GSK Consumer Healthcare announced its results for the quarter and year ended March 2016. During the quarter, sales and profit came in lower by 9% YoY and 8% YoY respectively.
GSK Consumer Healthcare announced its results for the quarter ended December 2015. While revenues were up by 2% YoY, profits were higher by 37% YoY.
More Views on NewsThe data tells us quite a different story from the one the government is trying to project.
The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.
Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...
The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.
Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...
More|
| |
Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.
Copyright © Equitymaster Agora Research Private Limited.
Whitelist | Refer | Terms | Privacy | Contact | Advertise | About | Sitemap
Equitymaster Agora Research Private Limited. 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407
All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.
LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA or Canada, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.
